Original Research

Published on 15 Oct 2024

Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response

in Cancer Immunity and Immunotherapy

Patrick Santos
Caroline P. Rezende
Renan Piraine
Bianca Oliveira
Francielle B. Ferreira
Vinicius S. Carvalho
Rodrigo T. Calado
Matteo Pellegrini
Fausto Almeida

Frontiers in Immunology

doi 10.3389/fimmu.2024.1468229

1,137 views

Original Research

Published on 15 Oct 2024

Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024

in Cancer Immunity and Immunotherapy

Kun Huang
Ye He
Hao Wan
Xiao-Xia Ban
Xin-Yu Chen
Xi-Min Hu
Xin-Xing Wan
Rui Lu
Qi Zhang
Kun Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1437570

948 views

Original Research

Published on 15 Oct 2024

PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop

in Cancer Immunity and Immunotherapy

Noor Abdala-Saleh
Jennie Lugassy
Akshatha Shivakumar-Kalvhati
Abeer Turky
Sari Abu Ras
Hila Razon
Nir Berger
Dana Bar-On
Yotam Bar-On
Tetsuya Taura

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452212

1,022 views

Original Research

Accepted on 14 Oct 2024

A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-inhuman, open-label, single center study

in Cancer Immunity and Immunotherapy

Na Song
Yuee Teng
Jing Shi
Zan Teng
Bo Jin
Jinglei Qu
Lingyun Zhang
Ping Yu
Lei Zhao
Jin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481326

112 views

Original Research

Published on 14 Oct 2024

Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma

in Cancer Immunity and Immunotherapy

Suxiao Li
Xiaoyan Feng
Yunfei Song
Mengke Fan
Qingjiang Chen
Mingzhi Zhang
Xiaolong Wu
Meng Dong
Jieming Zhang
Lijuan Han

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481301

589 views

Original Research

Published on 14 Oct 2024

HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance

in Cancer Immunity and Immunotherapy

Annalena Branz
Christian Matek
Fabienne Lange
Veronika Bahlinger
Niklas Klümper
Michael Hölzel
Pamela L. Strissel
Reiner Strick
Danijel Sikic
Sven Wach

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478196

954 views

Case Report

Published on 14 Oct 2024

Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report

in Cancer Immunity and Immunotherapy

Juan Ni
Xiaoyue Dong
Huafeng Shou
Qing Xu
Zhuomin Yin
Hanmei Lou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1434697

732 views

Editorial

Published on 14 Oct 2024

Editorial: Community series in the role of angiogenesis and immune response in tumor microenvironment of solid tumor, volume III

in Cancer Immunity and Immunotherapy

Fang Zheng
Zilong Chen
Wenqing Jia
Ren Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495465

279 views

Original Research

Published on 11 Oct 2024

Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape

in Cancer Immunity and Immunotherapy

Shuo-meng Xiao
Rui Xu
Ying-xin Yang
Rui Zhao
Yuan Xie
Xu-dan Lei
Xiao-ting Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1431535

791 views

Mini Review

Published on 11 Oct 2024

Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy

in Cancer Immunity and Immunotherapy

Minseo Ahn
Akhtar Ali
Jae Ho Seo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1453886

1,273 views

Original Research

Published on 11 Oct 2024

Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Huipeng Fang
Xingte Chen
Yaqi Zhong
Shiji Wu
Qiao Ke
Qizhen Huang
Lei Wang
Kun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446961

1,487 views

Review

Published on 11 Oct 2024

A nanoscale natural drug delivery system for targeted drug delivery against ovarian cancer: action mechanism, application enlightenment and future potential

in Cancer Immunity and Immunotherapy

Yi Li
Qian Shen
Lu Feng
Chuanlong Zhang
Xiaochen Jiang
Fudong Liu
Bo Pang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427573

1,067 views

Review

Published on 11 Oct 2024

Impact of mitochondrial dysfunction on the antitumor effects of immune cells

in Cancer Immunity and Immunotherapy

Quan Wang
Xiangzhi Yin
Xiaotong Huang
Lu Zhang
Haijun Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428596

977 views

Review

Published on 11 Oct 2024

Genomic instability as a driver and suppressor of anti-tumor immunity

in Cancer Immunity and Immunotherapy

Marta Requesens
Floris Foijer
Hans W. Nijman
Marco de Bruyn

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462496

973 views

Original Research

Published on 11 Oct 2024

PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis

in Cancer Immunity and Immunotherapy

Athina Boumpas
Antonis S. Papaioannou
Pavlos Bousounis
Maria Grigoriou
Veronica Bergo
Iosif Papafragkos
Athanasios Tasis
Michael Iskas
Louis Boon
Manousos Makridakis

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386838

1,292 views

Review

Published on 11 Oct 2024

Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy

in Cancer Immunity and Immunotherapy

Yurui Zhang
Yudi Wang
Peizheng Mu
Xiao Zhu
Yucui Dong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470468

1,117 views

Navigation group

Articles

Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response

Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024

PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop

A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-inhuman, open-label, single center study

Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma

HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance

Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report

Editorial: Community series in the role of angiogenesis and immune response in tumor microenvironment of solid tumor, volume III

Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape

Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy

Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinoma

A nanoscale natural drug delivery system for targeted drug delivery against ovarian cancer: action mechanism, application enlightenment and future potential

Impact of mitochondrial dysfunction on the antitumor effects of immune cells

Genomic instability as a driver and suppressor of anti-tumor immunity

PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis

Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy